Caligan Partners LP Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$520.2B
Holdings
17
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (17 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | VRNAVERONA PHARMA PLC | 1,436,878 | $135.9B | 26.13% | |
| 2 | LQDALIQUIDIA CORPORATION | 8,118,892 | $101.2B | 19.45% | |
| 3 | EX9EXELIXIS INC | 1,525,730 | $67.2B | 12.93% | |
| 4 | AGIOAGIOS PHARMACEUTICALS INC | 1,071,258 | $35.6B | 6.85% | |
| 5 | MRUSMERUS N V | 656,999 | $34.6B | 6.64% | |
| 6 | EOLSEVOLUS INC | 3,341,970 | $30.8B | 5.92% | |
| 7 | MLYSMINERALYS THERAPEUTICS INC | 2,017,352 | $27.3B | 5.25% | |
| 8 | RVMDREVOLUTION MEDICINES INC | 636,835 | $23.4B | 4.50% | |
| 9 | ANIKANIKA THERAPEUTICS INC | 1,435,130 | $15.2B | 2.92% | |
| 10 | ABVXABIVAX SA | 1,674,400 | $12.8B | 2.46% | |
| 11 | YMABUSDY-MABS THERAPEUTICS INC | 2,342,609 | $10.6B | 2.03% | |
| 12 | RZLTREZOLUTE INC | 1,543,014 | $6.9B | 1.32% | |
| 13 | BCRXBIOCRYST PHARMACEUTICALS INC | 638,908 | $5.7B | 1.10% | |
| 14 | SLSSELLAS LIFE SCIENCES GROUP I | 2,300,000 | $5.0B | 0.97% | Call |
| 15 | VRCAVERRICA PHARMACEUTICALS INC | 9,239,119 | $4.9B | 0.94% | |
| 16 | TYRATYRA BIOSCIENCES INC | 189,950 | $1.8B | 0.35% | |
| 17 | AURAAURA BIOSCIENCES INC | 200,000 | $1.3B | 0.24% |